共 50 条
- [21] EFFICACY AND PHARMACOKINETICS OF ORAL TESTOSTERONE (LPCN 1021) IN HYPOGONADAL MEN JOURNAL OF SEXUAL MEDICINE, 2016, 13 (05): : S14 - S14
- [22] SAFETY OF A NEW SEDDS FORMULATION OF ORAL TESTOSTERONE UNDECANOATE (TU) IN HYPOGONADAL MEN: DATA FROM TWO PHASE 3 TRIALS WITH DIFFERENT DOSE-TITRATION ALGORITHMS JOURNAL OF SEXUAL MEDICINE, 2015, 12 : 150 - 150
- [23] ASSESSMENT OF FASTING AND VARYING MEAL FAT CONTENT ON THE BIOAVAILABILITY OF ORAL TESTOSTERONE UNDECANOATE (LPCN 1021) IN HYPOGONADAL MEN JOURNAL OF SEXUAL MEDICINE, 2016, 13 (05): : S18 - S18
- [24] ORAL TESTOSTERONE UNDECANOATE (316 MG BID) QUICKLY AND EFFECTIVELY INCREASES SERUM TESTOSTERONE CONCENTRATIONS IN HYPOGONADAL MEN JOURNAL OF UROLOGY, 2024, 211 (05): : E1073 - E1073
- [28] TREATMENT OF HYPOGONADAL MEN WITH ORAL TESTOSTERONE UNDECANOATE (TU) IMPROVES PSYCHO-SEXUAL, WELL-BEING AND BODY COMPOSITION PARAMETERS JOURNAL OF UROLOGY, 2020, 203 : E547 - E547
- [29] ERECTILE FUNCTION IN 656 HYPOGONADAL MEN WITH AND WITHOUT LONG-TERM TREATMENT WITH TESTOSTERONE UNDECANOATE INJECTIONS (TU) JOURNAL OF SEXUAL MEDICINE, 2016, 13 (05): : S114 - S114
- [30] Comparison of Long-Acting Testosterone Undecanoate Formulation Versus Testosterone Enanthate on Sexual Function and Mood in Hypogonadal Men Editorial Comment JOURNAL OF UROLOGY, 2009, 182 (04): : 1508 - 1509